Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Miguel Martínez-FresnedaEmerging and Neglected Diseases Group, Health Sciences Faculty, Universidad Internacional SEK (UISEK), Quito 170120, Ecuador.ORCID 0000-0001-9595-8067
Esteban LizanoEmerging and Neglected Diseases Group, Health Sciences Faculty, Universidad Internacional SEK (UISEK), Quito 170120, Ecuador.
Gabriela Echeverría-GarcésExperimental and Applied Biomedicine Research Group, Health Sciences Faculty, Universidad Internacional SEK (UISEK), Quito 170120, Ecuador.ORCID 0000-0002-1941-7864
Andres Herrera-YelaEmerging and Neglected Diseases Group, Health Sciences Faculty, Universidad Internacional SEK (UISEK), Quito 170120, Ecuador.ORCID 0000-0002-6351-3650
Danna FeijóoEmerging and Neglected Diseases Group, Health Sciences Faculty, Universidad Internacional SEK (UISEK), Quito 170120, Ecuador.
Grecia Victoria Vivas-ColmenaresSchool of Medicine, Universidad Internacional SEK, Quito 170102, Ecuador.
Leda PedeliniMáster en Epidemiología y Salud Pública, Universidad Internacional de Valencia (VIU), 46002 Valencia, Spain.
Marta MendozaCentro de Estudios Biomédicos y Veterinarios (CEBIV), Instituto de Estudios Científicos y Tecnológicos (IDECYT), Universidad Nacional Experimental Simón Rodríguez (UNESR), Caracas 47925, Venezuela.
Juan Carlos NavarroEmerging and Neglected Diseases Group, Health Sciences Faculty, Universidad Internacional SEK (UISEK), Quito 170120, Ecuador.ORCID 0000-0002-7692-4248
Jose Ruben Ramírez-IglesiasEmerging and Neglected Diseases Group, Health Sciences Faculty, Universidad Internacional SEK (UISEK), Quito 170120, Ecuador.ORCID 0000-0003-0173-1895
Funding
Directorate of Research and Innovation, Universidad Internacional SEK (UISEK) DII-P011617_2
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Calmodulin Interaction Interface with Plasma Membrane Ca · full record | OpenQuestion